Special Considerations for the Analysis of Patient-Level Immuno-Oncology Data
Abstract
Research of immunotherapies in oncology requires alternative methods of observation and analysis to accurately assess their outcomes, due to their delayed clinical benefits and durable responses relative to conventional cytotoxic therapy (chemotherapy).